Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acumen Pharmaceuticals In...

    NASDAQ: ABOS · Real-Time Price · USD
    1.45
    0.05 (3.57%)
    At close: Aug 15, 2025, 12:52 PM

    Acumen Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 178K 42.32M 169K 4K
    Gross Profit
    		 -178K -42.32M -169K -4K
    Operating Income
    		 -114.02M -61.14M -45.24M -19.58M
    Interest Income
    		 14.32M 10.79M 2.39M 84K
    Pretax Income
    		 -102.33M -52.37M -42.86M -100.61M
    Net Income
    		 -102.33M -52.37M -42.86M -100.61M
    Selling & General & Admin
    		 20.22M 18.82M 12.88M 7.28M
    Research & Development
    		 93.8M 42.32M 32.36M 12.3M
    Other Expenses
    		 n/a n/a 1K n/a
    Operating Expenses
    		 114.02M 61.14M 45.24M 19.58M
    Interest Expense
    		 4.07M 581K n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 114.02M 61.14M 45.24M 19.58M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 60.01M 48.49M 40.6M 38.27M
    Shares Outstanding (Diluted)
    		 60.01M 48.61M 40.6M 38.27M
    EPS (Basic)
    		 -1.71 -1.08 -1.06 -2.63
    EPS (Diluted)
    		 -1.71 -1.08 -1.06 -2.63
    EBITDA
    		 -98.08M -51.61M -42.69M -19.58M
    EBIT
    		 -98.26M -51.79M -42.86M -19.58M
    Depreciation & Amortization
    		 178K 184K 169K 4K

    Add to Watchlist